Gitlab Inc. GTLB
4 trading plans running, 19 Form 144 notices for $155.6M
10-Q, 10-K and Form 144What GTLB's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.
Plans adopted or ended
Trading plans · XBRL, 10-Q and 10-K
From Dec 26, 2024 to Sep 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.
| Insider | What | Date | Reported in | ||
|---|---|---|---|---|---|
| Simon Mundy Chief Accounting Officer |
Adopted 10b5-1 plan | Jun 30, 2026 | 10-Q Sep 2, 2026 | ||
What the company wroteSimon Mundy 10b5-1 Plan On June 30, 2026, Simon Mundy, the Company’s Chief Accounting Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “New Mundy Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The New Mundy Rule 10b5-1 Plan will take effect on October 1, 2026 and on September 30, 2026 Mr. Mundy’s existing Rule 10b5-1 Plan will terminate according to its terms. The New Mundy Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The New Mundy Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the New Mundy Rule 10b5-1 Plan, between October 1, 2026 and September 30, 2027. The aggregate number of shares of Class A common stock that will be available for sale under the New Mundy Rule 10b5-1 Plan is not yet determinable because the shares available will be net of certain shares sold under Mr. Mundy’s prior pre-arranged written stock sale plan (the “Prior Mundy Rule 10b5-1 Plan”) and net of shares sold to satisfy tax withholding obligations that arise in connection with the settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of the Company’s Class A common stock available for sale is approximately 56,647 shares, which reflects the maximum number of shares of Class A common stock held by Mr. Mundy that may be sold under the plan, without excluding certain shares that may be sold under the Prior Mundy Rule 10b5-1 Plan, and the maximum number of shares underlying Mr. Mundy’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations, in each case so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the New Mundy Rule 10b5-1 Plan. The New Mundy Rule 10b5-1 Plan includes a representation from Mr. Mundy to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the New Mundy Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the New Mundy Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the New Mundy Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Mundy was unaware, or with respect to any material nonpublic information acquired by Mr. Mundy or the Company after the date of the representation. | |||||
| Sivaprasad Padisetty Chief Technology Officer |
Adopted 10b5-1 plan | Jun 29, 2026 | 10-Q Sep 2, 2026 | ||
What the company wroteSivaprasad Padisetty 10b5-1 Plan On June 29, 2026, Sivaprasad Padisetty, the Company’s Chief Technology Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Padisetty Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock, including such shares resulting from the vesting and settlement of restricted stock units. The Padisetty Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The aggregate number of shares of Class A common stock that will be available for sale under the Padisetty Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards and will include shares to be acquired through the Company’s Employee Stock Purchase Plan (the “ESPP”). As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 351,924 shares, which reflects the aggregate maximum number of shares underlying Mr. Padisetty’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations or including the shares to be acquired through the ESPP. The Padisetty Rule 10b5-1 Plan provides for an approximate selling start date of September 10, 2026 with an end date of September 30, 2027. The Padisetty Rule 10b5-1 Plan includes a representation from Mr. Padisetty to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Padisetty Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Padisetty Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Padisetty Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Padisetty was unaware, or with respect to any material nonpublic information acquired by Mr. Padisetty or the Company after the date of the representation. Once executed, transactions under each of the New Sijbrandij 10b5-1 Plan, New Mundy Rule 10b5-1 Plan and the Padisetty Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Mr. Sijbrandij, Mr. Mundy, Mr. Padisetty or other officers or directors of the Company. | |||||
| Sytse Sijbrandij Co-Founder and Executive Chair of the Board of Directors of the Company |
Ended 10b5-1 plan | Jun 25, 2026 | 10-Q Sep 2, 2026 | ||
What the company wroteSytse Sijbrandij 10b5-1 Plan On June 25, 2026, Sytse Sijbrandij, Co-Founder and Executive Chair of the Board of Directors of the Company, entered into, through Mr. Sijbrandij’s revocable trust (the “Trust”), a modification of a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of the Company’s Class A common stock owned by Mr. Sijbrandij through the Trust (the “Sijbrandij Plan Modification”). Under Rule 10b5-1, the Sijbrandij Plan Modification constituted a termination of an existing plan (the “Terminated Sijbrandij 10b5-1 Plan”) and an adoption of a new plan (the “New Sijbrandij 10b5-1 Plan”). Each of the Terminated Sijbrandij 10b5-1 Plan and the New Sijbrandij 10b5-1 Plan was entered into and, in the case of the Terminated Sijbrandij 10b5-1 Plan, modified or terminated, during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and was or is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, as applicable. The New Sijbrandij 10b5-1 Plan provides for the potential sale of approximately 6,292,736 shares so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the New Sijbrandij 10b5-1 Plan, between September 24, 2026 and August 18, 2027. The New Sijbrandij 10b5-1 Plan includes a representation from Mr. Sijbrandij to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the New Sijbrandij 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the New Sijbrandij 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the New Sijbrandij 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Sijbrandij was unaware, or with respect to any material nonpublic information acquired by Mr. Sijbrandij or the Company after the date of the representation. | |||||
| Sytse Sijbrandij Executive Chair of the Board of Directors |
Adopted 10b5-1 plan | Dec 19, 2025 | 10-K Mar 17, 2026 | ||
What the company wroteSytse Sijbrandij 10b5-1 Plan On December 19, 2025, Sytse Sijbrandij, Executive Chair of the Board of Directors, entered into, through Mr. Sibrandij’s revocable trust (the “Trust”), a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Sijbrandij Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock (resulting from the conversion of shares of the Company’s Class B common stock). The Sijbrandij Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Sijbrandij Rule 10b5-1 Plan provides for the potential sale of approximately 1,394,400 shares, which reflects the aggregate number of shares of the Company’s Class A common stock resulting from the conversion of shares of the Company’s Class B common stock, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Sijbrandij Rule 10b5-1 Plan, between April 15, 2026 and March 17, 2027. The Sijbrandij Rule 10b5-1 Plan includes a representation from Mr. Sijbrandij, on behalf of Trust, to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Sijbrandij Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Sijbrandij Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Sijbrandij Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Sijbrandij was unaware, or with respect to any material nonpublic information acquired by Mr. Sijbrandij or the Company after the date of the representation. Once executed, transactions under each of the Sijbrandij Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Mr. Sijbrandij or other officers or directors of the Company. | |||||
| James Shen Interim Chief Financial Officer |
Adopted 10b5-1 plan | Oct 1, 2025 | 10-Q Dec 3, 2025 | ||
What the company wroteJames Shen 10b5-1 Plan On October 1, 2025, James Shen, the Company’s Interim Chief Financial Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Shen Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock, including such shares resulting from the vesting and settlement of restricted stock units and from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options. The Shen Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The aggregate number of shares of Class A common stock that will be available for sale under the Shen Rule 10b5-1 Plan is not yet determinable because the shares available will be net of certain shares sold under Mr. Shen’s prior pre-arranged written stock sale plan entered into on December 23, 2024 (the “Prior Shen Rule 10b5-1 Plan”) and net of shares sold to satisfy tax withholding obligations that arise in connection with the settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of the Company’s Class A common stock available for sale is approximately 36,454 shares, which reflects shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options, the maximum number of shares of Class A common stock held by Mr. Shen that may be sold under the plan, without excluding certain shares that may be sold under the Prior Shulman Rule 10b5-1 Plan, and the maximum number of shares underlying Mr. Shen’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations, in each case so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Shen Rule 10b5-1 Plan between December 31, 2025 and March 12, 2027. The Shen Rule 10b5-1 Plan includes a representation from Mr. Shen to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Shen Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Shen Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Shen Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Shen was unaware, or with respect to any material nonpublic information acquired by Mr. Shen or the Company after the date of the representation. | |||||
| Robin Schulman Chief Legal Officer, Head of Corporate Affairs, and Corporate Secretary |
Adopted 10b5-1 plan | Oct 1, 2025 | 10-Q Dec 3, 2025 | ||
What the company wroteRobin Schulman 10b5-1 Plan On October 1, 2025, Robin Schulman, the Company’s Chief Legal Officer, Head of Corporate Affairs, and Corporate Secretary, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Schulman Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock, including such shares resulting from the vesting and settlement of restricted stock units and from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options. The Schulman Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The aggregate number of shares of Class A common stock that will be available for sale under the Schulman Rule 10b5-1 Plan is not yet determinable because the shares available will be net of certain shares sold under Ms. Schulman’s prior pre-arranged written stock sale plan entered into on October 1, 2024 (the “Prior Shulman Rule 10b5-1 Plan”) and net of shares sold to satisfy tax withholding obligations that arise in connection with the settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of the Company’s Class A common stock available for sale is approximately 411,886 shares, which reflects shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options, the maximum number of shares of Class A common stock held by Ms. Schulman that may be sold under the plan, without excluding certain shares that may be sold under the Prior Shulman Rule 10b5-1 Plan, and the maximum number of shares underlying Ms. Schulman’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations, in each case so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Schulman Rule 10b5-1 Plan between January 2, 2026 and December 31, 2026. The Schulman Rule 10b5-1 Plan includes a representation from Ms. Schulman to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Schulman Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Schulman Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Schulman Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Schulman was unaware, or with respect to any material nonpublic information acquired by Ms. Schulman or the Company after the date of the representation. | |||||
| William Staples Chief Executive Officer |
Adopted 10b5-1 plan | Sep 25, 2025 | 10-Q Dec 3, 2025 | ||
What the company wroteWilliam Staples 10b5-1 Plan On September 25, 2025, William Staples, the Company’s Chief Executive Officer, entered into a new pre-arranged written stock purchase plan in accordance with Rule 10b5-1 (the “Staples Rule 10b5-1 Plan”) for the purchase of shares of the Company’s Class A common stock. The Staples Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Staples Rule 10b5-1 Plan provides for the potential purchase of up to $125,000 of shares of the Company’s Class A common stock between December 31, 2025 and October 16, 2026, subject to conditions set forth in the Staples Rule 10b5-1 Plan, and so long as the market price of the Company’s Class A common stock is below certain threshold prices specified in the Staples Rule 10b5-1 Plan. The Staples Rule 10b5-1 Plan includes a representation from Mr. Staples to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Staples Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Staples Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Staples Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Staples was unaware, or with respect to any material nonpublic information acquired by Mr. Staples or the Company after the date of the representation. | |||||
| Merline Saintil member of the Company’s board of directors |
Adopted 10b5-1 plan | Mar 28, 2025 | 10-Q Jun 11, 2025 | ||
What the company wroteOn March 28, 2025, Merline Saintil, a member of the Company’s board of directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Saintil Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The Saintil Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Saintil Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Saintil Rule 10b5-1 Plan, between July 2, 2025 and December 31, 2025. The aggregate number of shares of Class A common stock that will be available for sale under the Saintil Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 1,214, which reflects the aggregate maximum number of shares underlying Ms. Saintil’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The Saintil Rule 10b5-1 Plan includes a representation from Ms. Saintil to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Saintil Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Saintil Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Saintil Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Saintil was unaware, or with respect to any material nonpublic information acquired by Ms. Saintil or the Company after the date of the representation. Once executed, transactions under each of the Saintil Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Ms. Saintil or other officers or directors of the Company. | |||||
| Brian Robins Chief Financial Officer |
Adopted 10b5-1 plan | Dec 31, 2024 | 10-K Mar 21, 2025 | ||
What the company wroteBrian Robins 10b5-1 Plan On December 31, 2024, Brian Robins, the Company’s Chief Financial Officer, along with The Robins Family Trust, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Robins Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options. The Robins Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Robins Rule 10b5-1 Plan provide for the potential sale of approximately 230,000 shares, which reflects shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Robins Rule 10b5-1 Plan between April 1, 2025 and February 27, 2026. The Robins Rule 10b5-1 Plan includes a representation from Mr. Robins and The Robins Family Trust trustee to the broker administering the plan that neither was in possession of any material nonpublic information regarding the Company or the securities subject to the Robins Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Robins Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Robins Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Robins or the trustee was unaware, or with respect to any material nonpublic information acquired by Mr. Robins, the trustee or the Company after the date of the representation. | |||||
| Sabrina Farmer Chief Technology Officer |
Adopted 10b5-1 plan | Dec 31, 2024 | 10-K Mar 21, 2025 | ||
What the company wroteSabrina Farmer 10b5-1 Plan On December 31, 2024, Sabrina Farmer, the Company’s Chief Technology Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Farmer Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock resulting from vesting and settlement of restricted stock units. The Farmer Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The aggregate number of shares of Class A common stock that will be available for sale under the Farmer Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock units. As such, for purposes of this disclosure, the aggregate number of shares of the Company’s Class A common stock available for sale is approximately 93,175 shares, which reflects the aggregate maximum number of shares underlying Ms. Farmer’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Farmer Rule 10b5-1 Plan between April 1, 2025 and December 26, 2025. The Farmer Rule 10b5-1 Plan includes a representation from Ms. Farmer to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Farmer Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Farmer Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Farmer Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Farmer was unaware, or with respect to any material nonpublic information acquired by Ms. Farmer or the Company after the date of the representation. | |||||
| Sytse Sijbrandij Co-Founder and Executive Chair of the Board of Directors |
Adopted 10b5-1 plan | Dec 26, 2024 | 10-K Mar 21, 2025 | ||
What the company wroteSytse Sijbrandij 10b5-1 Plan On December 26, 2024, Sytse Sijbrandij, Co-Founder and Executive Chair of the Board of Directors of the Company, entered into, through Mr. Sibrandij’s revocable trust and the Sijbrandij Foundation, a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Sijbrandij Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock resulting from the conversion of shares of the Company’s Class B common stock. The Sijbrandij Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Sijbrandij Rule 10b5-1 Plan provides for the potential sale of approximately 2,173,416 shares, which reflects the aggregate number of shares of the Company’s Class A common stock resulting from the conversion of shares of the Company’s Class B common stock, as applicable, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Sijbrandij Rule 10b5-1 Plan, between April 15, 2025 and March 18, 2026. The Sijbrandij Rule 10b5-1 Plan includes a representation from Mr. Sijbrandij to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Sijbrandij Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Sijbrandij Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Sijbrandij Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Sijbrandij was unaware, or with respect to any material nonpublic information acquired by Mr. Sijbrandij or the Company after the date of the representation. | |||||
| Robin Schulman Chief Legal Officer, Head of Corporate Affairs, and Corporate Secretary |
Adopted 10b5-1 plan | Oct 1, 2024 | 10-Q Dec 6, 2024 | ||
What the company wroteRobin Schulman New 10b5-1 Plan On October 1, 2024, Robin Schulman, the Company’s Chief Legal Officer, Head of Corporate Affairs, and Corporate Secretary, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1, or the New Schulman Rule 10b5-1 Plan, under the Exchange Act for the sale of shares of the Company’s Class A common stock, including shares of Class A common stock resulting from (i) vesting and settlement of restricted stock units and (ii) the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options. The New Schulman Rule 10b5-1 Plan will take effect on January 2, 2025, and on December 31, 2024 Ms. Schulman’s existing Rule 10b5-1 Plan will terminate according to its terms. The New Schulman Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The New Schulman Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units and exercise of vested stock options, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the New Schulman Rule 10b5-1 Plan, between January 2, 2025 and December 31, 2025. The aggregate number of shares of Class A common stock that will be available for sale under the New Schulman Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards and exercise and settlement of option awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 406,678, which reflects the aggregate maximum number of shares underlying Ms. Schulman’s restricted stock units and vested options which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The New Schulman Rule 10b5-1 Plan includes a representation from Ms. Schulman to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the New Schulman Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the New Schulman Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the New Schulman Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Schulman was unaware, or with respect to any material nonpublic information acquired by Ms. Schulman or the Company after the date of the representation. Once executed, transactions under the New Schulman Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Ms. Schulman or other officers or directors of the Company. | |||||
| Erin Mannix | Adopted 10b5-1 plan | Mar 28, 2024 | 10-Q Jun 4, 2024 | ||
What the company wroteErin Mannix New 10b5-1 Plan On March 28, 2024, Erin Mannix, the Company’s Chief Accounting Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “New Mannix Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The New Mannix Rule 10b5-1 Plan will take effect on July 1, 2024 and on June 28, 2024 Ms. Mannix’s existing Rule 10b5-1 Plan will terminate according to its terms. The New Mannix Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The New Mannix Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the New Mannix Rule 10b5-1 Plan, between July 1, 2024 and March 24, 2025. The aggregate number of shares of Class A common stock that will be available for sale under the New Mannix Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 17,797, which reflects the aggregate maximum number of shares underlying Ms. Mannix’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The New Mannix Rule 10b5-1 Plan includes a representation from Ms. Mannix to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the New Mannix Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the New Mannix Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the New Mannix Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Mannix was unaware, or with respect to any material nonpublic information acquired by Ms. Mannix or the Company after the date of the representation. Once executed, transactions under each of the Saintil Rule 10b5-1 Plan, the Blasing Rule 10b5-1 Plan and the New Mannix Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Ms. Saintil, Ms. Blasing, Ms. Mannix or other officers or directors of the Company. | |||||
| Merline Saintil member of the Company’s board of directors |
Adopted 10b5-1 plan | Mar 27, 2024 | 10-Q Jun 4, 2024 | ||
What the company wroteMerline Saintil 10b5-1 Plan On March 27, 2024, Merline Saintil, a member of the Company’s board of directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Saintil Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The Saintil Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Saintil Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Saintil Rule 10b5-1 Plan, between June 26, 2024 and March 31, 2025. The aggregate number of shares of Class A common stock that will be available for sale under the Saintil Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 2,511, which reflects the aggregate maximum number of shares underlying Ms. Saintil’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The Saintil Rule 10b5-1 Plan includes a representation from Ms. Saintil to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Saintil Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Saintil Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Saintil Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Saintil was unaware, or with respect to any material nonpublic information acquired by Ms. Saintil or the Company after the date of the representation. | |||||
| Karen Blasing | Adopted 10b5-1 plan | Mar 26, 2024 | 10-Q Jun 4, 2024 | ||
What the company wroteKaren Blasing 10b5-1 Plan On March 26, 2024, Karen Blasing, a member of the Company’s board of directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Blasing Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The Blasing Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Blasing Rule 10b5-1 Plan provides for the potential sale of up to 76,430 shares of the Company’s Class A common stock so long as in each case the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Blasing Rule 10b5-1 Plan, between June 25, 2024 and March 31, 2026. The aggregate number of shares of Class A common stock that will be available for sale under the Blasing Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the settlement of such already vested restricted stock unit awards and exercise and settlement of such stock options. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 76,430, which reflects the aggregate maximum number of shares underlying Ms. Blasing’s restricted stock units and stock options which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The Blasing Rule 10b5-1 Plan includes a representation from Ms. Blasing to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the Blasing Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Blasing Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Blasing Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Blasing was unaware, or with respect to any material nonpublic information acquired by Ms. Blasing or the Company after the date of the representation. | |||||
| Brian Robins Chief Financial Officer |
Adopted 10b5-1 plan | Dec 27, 2023 | 10-K Mar 26, 2024 | ||
What the company wroteBrian Robins 10b5-1 Plan On December 27, 2023, Brian Robins, the Company’s Chief Financial Officer, entered into a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Robins Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options. The Robins Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The aggregate number of shares of Class A common stock that will be available for sale under the Robins Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the exercise and settlement of option awards. As such, for purposes of this disclosure, the aggregate number of shares of the Company’s Class A common stock available for sale is approximately 240,000 shares, which reflects shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Robins Rule 10b5-1 Plan between March 27, 2024 and February 28, 2025. The Robins Rule 10b5-1 Plan includes a representation from Mr. Robins to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Robins Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Robins Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Robins Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Robins was unaware, or with respect to any material nonpublic information acquired by Mr. Robins or the Company after the date of the representation. Once executed, transactions under each of the Sijbrandij Rule 10b5-1 Plan and the Robins Rule 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Mr. Sijbrandij, Mr. Robins or other officers or directors of the Company. | |||||
| Sytse Sijbrandij Co-Founder, Chair of the board of directors, and Chief Executive Officer |
Adopted 10b5-1 plan | Dec 26, 2023 | 10-K Mar 26, 2024 | ||
What the company wroteSytse Sijbrandij 10b5-1 Plan On December 26, 2023, Sytse Sijbrandij, Co-Founder, Chair of the board of directors, and Chief Executive Officer, entered into, through Mr. Sibrandij’s revocable trust, a new pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Sijbrandij Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock (resulting from the conversion of the Company’s Class B common stock). The Sijbrandij Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Sijbrandij Rule 10b5-1 Plan provides for the potential sale of approximately 1,008,000 shares, which reflects the aggregate number of shares of the Company’s Class A common stock resulting from the conversion of the Company’s Class B common stock, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Sijbrandij Rule 10b5-1 Plan, between April 15, 2024 and March 19, 2025. The Sijbrandij Rule 10b5-1 Plan includes a representation from Mr. Sijbrandij to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Sijbrandij Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Sijbrandij Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Sijbrandij Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Sijbrandij was unaware, or with respect to any material nonpublic information acquired by Mr. Sijbrandij or the Company after the date of the representation. | |||||
| Robin Schulman Company’s Chief Legal Officer, Head of Corporate Affairs, and Corporate Secretary |
Ended 10b5-1 plan | Sep 29, 2023 | 10-Q Dec 5, 2023 | ||
What the company wroteOn September 29, 2023, Robin Schulman, the Company’s Chief Legal Officer, Head of Corporate Affairs, and Corporate Secretary, entered into a modification of a pre-arranged written stock sale plan in accordance with Rule 10b5-1 under the Exchange Act for the sale of shares of the Company’s Class A common stock owned by Ms. Schulman, to define the number of the shares to be sold in certain instances rather than having any contingent amounts, adjust the price limits, and increase the maximum number of shares that can be sold in certain instances (the “Schulman Plan Modification”). Under Rule 10b5-1, the Schulman Plan Modification constituted a termination of an existing plan (the “Terminated Schulman 10b5-1 Plan”) and an adoption of a new plan (the “New Schulman 10b5-1 Plan”). Each of the Terminated Schulman 10b5-1 Plan and the New Schulman 10b5-1 Plan was entered into and, in the case of the Terminated Schulman 10b5-1 Plan, modified or terminated, during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and was or is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, as applicable. The aggregate number of shares of Class A common stock that will be available for sale under the New Schulman 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of the Company’s Class A common stock available for sale is approximately 501,909 shares, which reflects (i) the aggregate maximum number of shares underlying Ms. Schulman’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations and (ii) shares of the Company’s Class A common stock resulting from the exercise of vested stock options for shares of the Company’s Class B common stock and subsequent conversion to Class A common stock prior to consummating any sale in connection with the exercise of vested stock options, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the New Schulman 10b5-1 Plan between December 29, 2023 and December 31, 2024. The New Schulman 10b5-1 Plan includes a representation from Ms. Schulman to the broker administering the plan that she was not in possession of any material nonpublic information regarding the Company or the securities subject to the New Schulman 10b5-1 Plan at the time the New Schulman 10b5-1 Plan was entered into. A similar representation was made to the Company in connection with the adoption of the New Schulman 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the New Schulman 10b5-1 Plan, and speak only as of that date. In making those representations, there is no assurance with respect to any material nonpublic information of which Ms. Schulman was unaware, or with respect to any material nonpublic information acquired by Ms. Schulman after the date of the representation. Once executed, transactions under each of the Porter Rule 10b5-1 Plan and New Schulman 10b5-1 Plan will be disclosed publicly through Form 4 and/or Form 144 filings with the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be required by law, the Company does not undertake any obligation to update or report any modification, termination, or other activity under current or future Rule 10b5-1 plans that may be adopted by Mr. Porter, Ms. Schulman or other officers or directors of the Company. | |||||
| Mark Porter member of the Company’s board of directors |
Adopted 10b5-1 plan | Sep 15, 2023 | 10-Q Dec 5, 2023 | ||
What the company wroteOn September 15, 2023, Mark Porter, a member of the Company’s board of directors, entered into a pre-arranged written stock sale plan in accordance with Rule 10b5-1 (the “Porter Rule 10b5-1 Plan”) under the Exchange Act for the sale of shares of the Company’s Class A common stock. The Porter Rule 10b5-1 Plan was entered into during an open trading window in accordance with the Company’s policies regarding transactions in the Company’s securities and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Porter Rule 10b5-1 Plan provides for the potential sale of shares of the Company’s Class A common stock, including upon the vesting and settlement of restricted stock units, so long as the market price of the Company’s Class A common stock is higher than certain minimum threshold prices specified in the Porter Rule 10b5-1 Plan, between December 15, 2023 and September 13, 2024. The aggregate number of shares of Class A common stock that will be available for sale under the Porter Rule 10b5-1 Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations that arise in connection with the vesting and settlement of such restricted stock unit awards. As such, for purposes of this disclosure, the aggregate number of shares of Class A common stock available for sale is approximately 6,376, which reflects the aggregate maximum number of shares underlying Mr. Porter’s restricted stock units which may be sold, without excluding the shares that will be sold to satisfy the tax withholding obligations. The Porter Rule 10b5-1 Plan includes a representation from Mr. Porter to the broker administering the plan that he was not in possession of any material nonpublic information regarding the Company or the securities subject to the Porter Rule 10b5-1 Plan at the time it was entered into. A similar representation was made to the Company in connection with the adoption of the Porter Rule 10b5-1 Plan under the Company’s policies regarding transactions in the Company’s securities. Those representations were made as of the date of adoption of the Porter Rule 10b5-1 Plan, and speak only as of such date. In making those representations, there is no assurance with respect to any material nonpublic information of which Mr. Porter was unaware, or with respect to any material nonpublic information acquired by Mr. Porter or the Company after the date of the representation. | |||||
| Erin Mannix Principal Accounting Officer and Chief Accounting Officer |
Adopted 10b5-1 plan | Jun 26, 2023 | 10-Q Sep 6, 2023 | ||
Show the other 12 plans
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 14 filings checked since Jun 6, 2023.
Notices of planned sales
Form 144 · Form 144 XML, SEC
What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).
| Filed | Seller | Shares | Value |
|---|---|---|---|
| Oct 19, 2026 | Sytse Sijbrandij Revocable Trust Director |
348,600 | $18.4M |
| Oct 9, 2026 | ROBIN SCHULMAN Officer |
49,936 | $2.7M |
| Oct 1, 2026 | SIMON MUNDY Officer |
9,132 | $431K |
| Sep 28, 2026 | SIVAPRASAD PADISETTY Officer |
51,915 | $2.4M |
| Sep 24, 2026 | SYTSE SIJBRANDIJ REVOCABLE TRUST Director |
2,116,200 | $103.7M |
| Sep 18, 2026 | SIMON MUNDY Officer |
2,934 | $147K |
| Sep 2, 2026 | ROBIN SCHULMAN Officer |
21,183 | $955K |
| Aug 7, 2026 | SIMON MUNDY Officer |
8,725 | $311K |
| Apr 15, 2026 | SYTSE SIJBRANDIJ REVOCABLE TRUST Director, Officer, 10% Stockholder |
348,600 | $7.0M |
| Mar 27, 2026 | SUSAN L BOSTROM Director |
32,500 | $662K |
| Mar 24, 2026 | SABRINA FARMER Officer |
66,791 | $1.4M |
| Feb 17, 2026 | SYTSE SIJBRANDIJ REVOCABLE TRUST Director, 10% Stockholder |
108,600 | $3.2M |
| Dec 31, 2025 | JAMES QIMENG SHEN Officer |
2,538 | $97K |
| Dec 18, 2025 | SIMON MUNDY Officer |
2,756 | $104K |
| Dec 18, 2025 | BRIAN ROBINS Officer |
132,500 | $5.1M |
| Dec 17, 2025 | BRIAN ROBINS Officer |
131,250 | $5.0M |
| Dec 16, 2025 | SIMON MUNDY Officer |
723 | $28K |
| Dec 9, 2025 | SUSAN L BOSTROM Director |
30,000 | $1.2M |
| Dec 8, 2025 | SUSAN L BOSTROM Director |
70,000 | $2.8M |
Show the other 11 notices
From the Form 144 XML filed with the SEC, since Dec 8, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Sources
Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.
Also
Insider trades: the Form 4s for the sales these plans led to.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GTLB/export.csv") into a cell.